$EXPO
EXPONENT INC

2022 Q1 Form 10-K Financial Statement

#000156459022007169 Filed on February 25, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $116.4M $103.2M
YoY Change 17.98% -6.28%
Cost Of Revenue $7.938M $5.900M
YoY Change 52.65% -25.32%
Gross Profit $108.5M $97.30M
YoY Change 16.01% -4.79%
Gross Profit Margin 93.18% 94.28%
Selling, General & Admin $70.28M $71.10M
YoY Change 4.27% -3.79%
% of Gross Profit 64.79% 73.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.645M $1.700M
YoY Change -3.24% -10.53%
% of Gross Profit 1.52% 1.75%
Operating Expenses $76.35M $79.60M
YoY Change 4.44% -1.61%
Operating Profit $32.12M $17.70M
YoY Change 57.39% -17.1%
Interest Expense $13.00K $200.0K
YoY Change -95.67% -80.0%
% of Operating Profit 0.04% 1.13%
Other Income/Expense, Net $257.0K $8.900M
YoY Change -93.44% 102.27%
Pretax Income $32.39M $26.83M
YoY Change 31.46% 0.09%
Income Tax $7.815M $5.000M
% Of Pretax Income 24.13% 18.64%
Net Earnings $24.57M $21.84M
YoY Change 35.89% 14.22%
Net Earnings / Revenue 21.11% 21.16%
Basic Earnings Per Share $0.47 $0.42
Diluted Earnings Per Share $460.9K $0.41
COMMON SHARES
Basic Shares Outstanding 52.62M 52.40M
Diluted Shares Outstanding 53.31M 53.26M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $254.8M $242.5M
YoY Change 22.67% 4.71%
Cash & Equivalents $297.7M $197.5M
Short-Term Investments $25.00M $45.00M
Other Short-Term Assets $18.74M $12.70M
YoY Change 70.35% 3.25%
Inventory
Prepaid Expenses
Receivables $139.9M $111.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $452.8M $366.8M
YoY Change 37.79% 0.77%
LONG-TERM ASSETS
Property, Plant & Equipment $59.97M $59.82M
YoY Change -25.5% -2.86%
Goodwill $8.607M $8.607M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.521M $1.242M
YoY Change -98.7% 30.87%
Total Long-Term Assets $231.0M $213.3M
YoY Change 12.07% 6.97%
TOTAL ASSETS
Total Short-Term Assets $452.8M $366.8M
Total Long-Term Assets $231.0M $213.3M
Total Assets $683.7M $580.1M
YoY Change 27.87% 2.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.44M $3.279M
YoY Change 15.28% -29.39%
Accrued Expenses $92.78M $13.05M
YoY Change 35.65% -6.39%
Deferred Revenue $19.76M $11.80M
YoY Change -7.16%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $153.0M $117.3M
YoY Change 58.7% -5.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.886M $2.986M
YoY Change -96.97% 11.88%
Total Long-Term Liabilities $2.886M $2.986M
YoY Change -96.97% 11.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $153.0M $117.3M
Total Long-Term Liabilities $2.886M $2.986M
Total Liabilities $266.7M $218.6M
YoY Change 39.26% 2.55%
SHAREHOLDERS EQUITY
Retained Earnings $478.4M $421.8M
YoY Change 9.66%
Common Stock $281.5M $265.4M
YoY Change 8.32%
Preferred Stock
YoY Change
Treasury Stock (at cost) $340.8M $323.8M
YoY Change 16.61%
Treasury Stock Shares $13.59M $13.90M
Shareholders Equity $417.1M $361.5M
YoY Change
Total Liabilities & Shareholders Equity $683.7M $580.1M
YoY Change 27.87% 2.96%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income $24.57M $21.84M
YoY Change 35.89% 14.22%
Depreciation, Depletion And Amortization $1.645M $1.700M
YoY Change -3.24% -10.53%
Cash From Operating Activities $24.93M $40.90M
YoY Change -11.61% -26.7%
INVESTING ACTIVITIES
Capital Expenditures -$1.191M -$900.0K
YoY Change -25.56% -85.0%
Acquisitions
YoY Change
Other Investing Activities -$25.00M -$25.00M
YoY Change -278.55% -213.64%
Cash From Investing Activities -$26.19M -$25.90M
YoY Change -311.19% -261.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.769M -6.200M
YoY Change -5.71% -78.62%
NET CHANGE
Cash From Operating Activities 24.93M 40.90M
Cash From Investing Activities -26.19M -25.90M
Cash From Financing Activities -8.769M -6.200M
Net Change In Cash -10.03M 8.800M
YoY Change -132.05% -79.44%
FREE CASH FLOW
Cash From Operating Activities $24.93M $40.90M
Capital Expenditures -$1.191M -$900.0K
Free Cash Flow $26.12M $41.80M
YoY Change -12.36% -32.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M6D
CY2021 dei Auditor Name
AuditorName
KPMG, LLP
CY2021 dei Auditor Location
AuditorLocation
San Francisco, California
CY2021 dei Auditor Firm
AuditorFirmId
185
CY2021 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
434850000
CY2021 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
378412000
CY2020 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
391390000
CY2021 expo Revenue From Reimbursement
RevenueFromReimbursement
31419000
CY2021 expo Revenue From Reimbursement
RevenueFromReimbursement
21488000
CY2020 expo Revenue From Reimbursement
RevenueFromReimbursement
25809000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
466269000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
399900000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417199000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
278047000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
250041000
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
252197000
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
32594000
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
32234000
CY2020 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
33562000
CY2021 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
31419000
CY2021 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
21488000
CY2020 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
25809000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15282000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12888000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20520000
CY2021 us-gaap Operating Expenses
OperatingExpenses
357342000
CY2021 us-gaap Operating Expenses
OperatingExpenses
316651000
CY2020 us-gaap Operating Expenses
OperatingExpenses
332088000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
108927000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
83249000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
85111000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
66000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
1705000
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
3912000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16844000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11982000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15167000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
125837000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
96936000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
104190000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24635000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14384000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21730000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
101202000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
82552000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
82460000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.92
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.58
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.56
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.90
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.55
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.53
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3544000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
103312000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
108059000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6826000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4987000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52610000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52388000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52691000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53331000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53323000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53884000
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.80
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.76
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.64
CY2021 us-gaap Net Income Loss
NetIncomeLoss
101202000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
82552000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
82460000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
14000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
65000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
145000
CY2021 expo Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment On Planned Disposal Of Subsidiary Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentOnPlannedDisposalOfSubsidiaryTax
0
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-601000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-79000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
114000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-65000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-237000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
347000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
101151000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
82380000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
83553000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
297687000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
197525000
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
45001000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3995000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139861000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
111565000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15214000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12741000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
452762000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
366832000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59971000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59823000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14370000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19322000
CY2021Q4 us-gaap Goodwill
Goodwill
8607000
CY2021Q1 us-gaap Goodwill
Goodwill
8607000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
46546000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
40539000
CY2021Q4 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
99962000
CY2021Q1 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
83731000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1521000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1242000
CY2021Q4 us-gaap Assets
Assets
683739000
CY2021Q1 us-gaap Assets
Assets
580096000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
24504000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
66000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
66000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
281419000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
265328000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
65000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1997000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1932000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
421809000
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
13903000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
145000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-601000
CY2020 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7947000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-11183000
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16327000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
103552000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83194000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19762000
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
11800000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5164000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5987000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
152982000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
117308000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2886000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2986000
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
100999000
CY2021Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
83961000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9807000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14343000
CY2021Q4 us-gaap Liabilities
Liabilities
266674000
CY2021Q1 us-gaap Liabilities
Liabilities
218598000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
323773000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
361498000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
580096000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
313909000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1561000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8710000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
21957000
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
347000
CY2020 us-gaap Dividends
Dividends
33957000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
82460000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
350251000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1791000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4940000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9165000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
40049000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
65000
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
8645000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15263000
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-237000
CY2021 us-gaap Dividends
Dividends
40362000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
82552000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
361498000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1977000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1134000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9296000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7000000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7637000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15666000
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-6000
CY2021 us-gaap Dividends
Dividends
43021000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
101202000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417065000
CY2021 us-gaap Profit Loss
ProfitLoss
101202000
CY2021 us-gaap Profit Loss
ProfitLoss
82552000
CY2020 us-gaap Profit Loss
ProfitLoss
82460000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6487000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6871000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6806000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
11000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
163000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
516000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1958000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1849000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2224000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
19263000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
17278000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
17466000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6005000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3639000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2845000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30254000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6724000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16548000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4407000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9075000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3343000
CY2021 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
406000
CY2021 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
91000
CY2020 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
-205000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8443000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2646000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
20336000
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
34994000
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
38693000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
50000000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
66000000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
38178000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5024000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4269000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15666000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15263000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11183000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7000000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
40049000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21957000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3111000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6732000
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
43198000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-63414000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1108000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
463000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
100162000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21089000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
49377000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176436000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127059000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
297687000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197525000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176436000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Estimates are used for, but not limited to, revenue recognition, allowance for contract losses and doubtful accounts, stock-based compensation, income taxes, goodwill, the useful life of property, equipment and leasehold improvements, and operating lease liabilities. Actual results could differ from those estimates.</p>
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
210923000
CY2021Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
110379000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
110379000
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
185190000
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
88977000
CY2021Q1 us-gaap Land
Land
18339000
CY2021Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
62324000
CY2021Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
650000
CY2021Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
48728000
CY2021Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10500000
CY2021Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
13201000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
153742000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
93919000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59823000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6806000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3995000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
111565000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3279000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13048000
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16327000
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
51126000
CY2021Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
9127000
CY2021Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
13174000
CY2021Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
5016000
CY2021Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
4751000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83194000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
8017000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
16498000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1523000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6554000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
24575000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1727000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1118000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2845000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21730000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
21880000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
5174000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2942000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
4129000
CY2021 expo Income Tax Rate Reconciliation Divestiture Of Foreign Subsidiary
IncomeTaxRateReconciliationDivestitureOfForeignSubsidiary
0
CY2021 expo Income Tax Rate Reconciliation Divestiture Of Foreign Subsidiary
IncomeTaxRateReconciliationDivestitureOfForeignSubsidiary
46000
CY2020 expo Income Tax Rate Reconciliation Divestiture Of Foreign Subsidiary
IncomeTaxRateReconciliationDivestitureOfForeignSubsidiary
956000
CY2021 expo Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation
IncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensation
997000
CY2021 expo Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation
IncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensation
907000
CY2020 expo Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation
IncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensation
759000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
19000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
118000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
345000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
13000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-14000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
2000
CY2021 expo Income Tax Reconciliation Excess Tax Benefit From Share Based Compensation
IncomeTaxReconciliationExcessTaxBenefitFromShareBasedCompensation
7850000
CY2021 expo Income Tax Reconciliation Excess Tax Benefit From Share Based Compensation
IncomeTaxReconciliationExcessTaxBenefitFromShareBasedCompensation
9725000
CY2020 expo Income Tax Reconciliation Excess Tax Benefit From Share Based Compensation
IncomeTaxReconciliationExcessTaxBenefitFromShareBasedCompensation
6394000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-622000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-486000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-341000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
478000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
239000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
394000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24635000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14384000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21730000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.148
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
17914000
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
16841000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
38167000
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
31619000
CY2021Q4 expo Deferred Tax Assets Operating Leases
DeferredTaxAssetsOperatingLeases
4298000
CY2021Q1 expo Deferred Tax Assets Operating Leases
DeferredTaxAssetsOperatingLeases
5758000
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
120000
CY2021Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
60499000
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
54218000
CY2021Q4 expo Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
2062000
CY2021Q1 expo Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
1969000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
2120000
CY2021Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
2091000
CY2021Q4 expo Deferred Tax Liabilities Operating Leases
DeferredTaxLiabilitiesOperatingLeases
4298000
CY2021Q1 expo Deferred Tax Liabilities Operating Leases
DeferredTaxLiabilitiesOperatingLeases
5758000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
81000
CY2021Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
5336000
CY2021Q1 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
3545000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
137000
CY2021Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
235000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
13953000
CY2021Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
13679000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
46546000
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
40539000
CY2021 expo Total Excess Tax Benefit From Share Based Compensation
TotalExcessTaxBenefitFromShareBasedCompensation
10009000
CY2021 expo Total Excess Tax Benefit From Share Based Compensation
TotalExcessTaxBenefitFromShareBasedCompensation
12258000
CY2020 expo Total Excess Tax Benefit From Share Based Compensation
TotalExcessTaxBenefitFromShareBasedCompensation
8067000
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1923000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
275000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
325000
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1873000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
478000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
402000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1949000
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1571000
CY2021 expo Unrecognized Liability For Uncertain Tax Positions For Next Twelve Months
UnrecognizedLiabilityForUncertainTaxPositionsForNextTwelveMonths
0
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.200
CY2021Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10423000
CY2021Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.200
CY2021Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10419000
CY2021Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.200
CY2021Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10421000
CY2021Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.200
CY2021Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10423000
CY2021 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
1679000
CY2021 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
4538000
CY2020 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5146000
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
78000
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7000000
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
636000
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
40049000
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
342000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
21957000
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
45000000
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000
CY2021Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
68455000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
32000000.0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
31300000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
25600000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
97.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
68.21
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
57.08
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
568039000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
418394
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.29
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
33333
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
94.20
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
48000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
23.63
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
29519000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
290894
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
33.67
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
24163000
CY2020 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
12834000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4335000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
18211000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9651000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.32
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
19.73
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.16
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
19263000
us-gaap Share Based Compensation
ShareBasedCompensation
17278000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
17466000
CY2021 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
10009000
expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
12258000
CY2020 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
8067000
CY2021 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07
CY2021 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07
CY2021 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07
CY2021 expo Defined Contribution Plan Employer Contribution Annual Vesting Percentage
DefinedContributionPlanEmployerContributionAnnualVestingPercentage
0.20
CY2021 expo Defined Contribution Plan Employer Contribution Annual Vesting Period
DefinedContributionPlanEmployerContributionAnnualVestingPeriod
P5Y
CY2021 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
9923000
CY2021 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
9752000
CY2020 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
9073000
CY2021Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
109342000
CY2021Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
88747000
CY2021Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
110379000
CY2021Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
88977000
CY2021 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
14730000
CY2021 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
8028000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
6962000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
16763000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1792000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
14971000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
29480000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q1 us-gaap Goodwill
Goodwill
8607000
CY2021Q4 us-gaap Goodwill
Goodwill
8607000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
CY2022Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2022-03-25
CY2022Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2022-03-11
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000000

Files In Submission

Name View Source Status
0001564590-22-007169-index-headers.html Edgar Link pending
0001564590-22-007169-index.html Edgar Link pending
0001564590-22-007169.txt Edgar Link pending
0001564590-22-007169-xbrl.zip Edgar Link pending
expo-10k_20211231.htm Edgar Link pending
expo-10k_20211231_htm.xml Edgar Link completed
expo-20211231.xsd Edgar Link pending
expo-20211231_cal.xml Edgar Link unprocessable
expo-20211231_def.xml Edgar Link unprocessable
expo-20211231_lab.xml Edgar Link unprocessable
expo-20211231_pre.xml Edgar Link unprocessable
expo-ex1018_309.htm Edgar Link pending
expo-ex211_12.htm Edgar Link pending
expo-ex231_242.htm Edgar Link pending
expo-ex311_7.htm Edgar Link pending
expo-ex312_13.htm Edgar Link pending
expo-ex321_10.htm Edgar Link pending
expo-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ge33fdctb23c000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending